"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"

Clinical trial NCT04641780 · UNKNOWN

Trial details

NCT number: NCT04641780
Sponsor: Otsuka Pharmaceutical, Inc., Philippines
Status: UNKNOWN
Study type: OBSERVATIONAL

Schizophrenia Major Depressive Disorder

Start date: 2019-08-17
Primary completion: 2023-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.